2018-08-06 Comments Off on Otonomy Initiates Phase 3 Clinical Trial of Otividex in Ménière’s Disease Otonomy Initiates Phase 3 Clinical Trial of Otividex in Ménière’s Disease SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) — Otonomy, Inc.